Title

Remdesivir in a pregnant patient with COVID-19 pneumonia

Document Type

Article

Publication Title

Journal of Community Hospital Internal Medicine Perspectives

Abstract

Remdesivir is an antiviral drug currently being studied as a potential treatment of pneumonia caused by infection with SARS-CoV-2. The Adaptive Covid-19 Treatment Trial (ACTT-1) by NIH and the SIMPLE study by Gilead Sciences are two major trials that showed promising results of Remdesivir in the non-pregnant population. We are presenting the case of a pregnant patient who was diagnosed with COVID-19 pneumonia and successfully treated with Remdesivir.

First Page

103

Last Page

106

DOI

https://doi.org/10.1080/20009666.2020.1857510

Publication Date

Winter 1-26-2021

Link to Full Text

Share

COinS